The Impella 2.5 percutaneous left ventricular assist device may be a viable treatment option for managing cardiogenic shock secondary to severe acute ischemic mitral regurgitation.
May support Impella in cardiogenic shock from acute ischemic MR; hypothesis-generating from single case, needs prospective validation.
We report a case of a patient successfully treated with an Impella Recover LP 2.5 (ABIOMED, Danvers, MA) left ventricular assist device, in the setting of cardiogenic shock secondary to severe acute mitral regurgitation associated with an acute myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Harmon et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: